BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

732 related articles for article (PubMed ID: 24607302)

  • 21. Induction of host protective Th1 immune response by chemokines in Leishmania donovani-infected BALB/c mice.
    Dey R; Majumder N; Bhattacharyya Majumdar S; Bhattacharjee S; Banerjee S; Roy S; Majumdar S
    Scand J Immunol; 2007 Dec; 66(6):671-83. PubMed ID: 18021365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A Defective Oxidative Burst and Impaired Antigen Presentation are Hallmarks of Human Visceral Leishmaniasis.
    Roy S; Mukhopadhyay D; Mukherjee S; Ghosh S; Kumar S; Sarkar K; Pal D; Bhowmik P; Mandal K; Modak D; Guha SK; Pramanik N; Goswami RP; Saha B; Chatterjee M
    J Clin Immunol; 2015 Jan; 35(1):56-67. PubMed ID: 25479930
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Malnutrition alters the innate immune response and increases early visceralization following Leishmania donovani infection.
    Anstead GM; Chandrasekar B; Zhao W; Yang J; Perez LE; Melby PC
    Infect Immun; 2001 Aug; 69(8):4709-18. PubMed ID: 11447142
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.
    Kemp M; Kurtzhals JA; Bendtzen K; Poulsen LK; Hansen MB; Koech DK; Kharazmi A; Theander TG
    Infect Immun; 1993 Mar; 61(3):1069-73. PubMed ID: 8432588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interferon-gamma and interleukin-4 production by human T cells recognizing Leishmania donovani antigens separated by SDS-PAGE.
    Bahrenscheer J; Kemp M; Kurtzhals JA; Gachihi GS; Kharazmi A; Theander TG
    APMIS; 1995 Feb; 103(2):131-9. PubMed ID: 7748537
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T cell subset and cytokine profiles in human visceral leishmaniasis during active and asymptomatic or sub-clinical infection with Leishmania donovani.
    Hailu A; van Baarle D; Knol GJ; Berhe N; Miedema F; Kager PA
    Clin Immunol; 2005 Nov; 117(2):182-91. PubMed ID: 16125466
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum chemokine profiles in visceral leishmaniasis, HIV and HIV/ visceral leishmaniasis co-infected Ethiopian patients.
    Sisay Z; Berhe N; Petros B; Tegbaru B; Messele T; Hailu A; Wolday D
    Ethiop Med J; 2011 Jul; 49(3):179-86. PubMed ID: 21991751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV-1 alters T helper cytokines, interleukin-12 and interleukin-18 responses to the protozoan parasite Leishmania donovani.
    Wolday D; Berhe N; Britton S; Akuffo H
    AIDS; 2000 May; 14(8):921-9. PubMed ID: 10853973
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of Leishmania donovani disulfide isomerase as a potential target of cellular immunity against visceral leishmaniasis.
    Amit A; Chaudhary R; Yadav A; Suman SS; Narayan S; Das VN; Pandey K; Singh SK; Singh BK; Ali V; Das P; Bimal S
    Cell Immunol; 2014; 289(1-2):76-85. PubMed ID: 24732062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Parasite accessory cell interactions in murine leishmaniasis. I. Evasion and stimulus-dependent suppression of the macrophage interleukin 1 response by Leishmania donovani.
    Reiner NE
    J Immunol; 1987 Mar; 138(6):1919-25. PubMed ID: 3493291
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of the immune response and infection pattern to Leishmania donovani in visceral leishmaniasis due to arsenic exposure: An in vitro study.
    Ahmed G; Thakur AK; Pushpanjali ; Snehil ; Chaturvedi SK; Shivam P; Jamal F; Singh MK; Bimal S; Singh SK; Choudhary SK; Das P; Narayan S
    PLoS One; 2019; 14(2):e0210737. PubMed ID: 30721235
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
    Sato N; Kuziel WA; Melby PC; Reddick RL; Kostecki V; Zhao W; Maeda N; Ahuja SK; Ahuja SS
    J Immunol; 1999 Nov; 163(10):5519-25. PubMed ID: 10553079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-Interleukin-10 Unleashes Transcriptional Response to Leishmanial Antigens in Visceral Leishmaniasis Patients.
    Singh OP; Syn G; Nylén S; Engwerda C; Sacks D; Wilson ME; Kumar R; Chakravarty J; Sundar S; Blackwell JM; Fakiola M
    J Infect Dis; 2021 Feb; 223(3):517-521. PubMed ID: 32614452
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytosolic tryparedoxin of Leishmania donovani modulates host immune response in visceral leishmaniasis.
    Suman SS; Amit A; Singh KP; Gupta P; Equbal A; Kumari A; Topno RK; Ravidas V; Pandey K; Bimal S; Das P; Ali V
    Cytokine; 2018 Aug; 108():1-8. PubMed ID: 29554571
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leishmania exosomes modulate innate and adaptive immune responses through effects on monocytes and dendritic cells.
    Silverman JM; Clos J; Horakova E; Wang AY; Wiesgigl M; Kelly I; Lynn MA; McMaster WR; Foster LJ; Levings MK; Reiner NE
    J Immunol; 2010 Nov; 185(9):5011-22. PubMed ID: 20881185
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Leishmania donovani influenced cytokines and Toll-like receptors expression among Sudanese visceral leishmaniasis patients.
    Babiker DT; Bakhiet SM; Mukhtar MM
    Parasite Immunol; 2015 Aug; 37(8):417-25. PubMed ID: 25982946
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The IL-33/ST2 axis is associated with human visceral leishmaniasis and suppresses Th1 responses in the livers of BALB/c mice infected with Leishmania donovani.
    Rostan O; Gangneux JP; Piquet-Pellorce C; Manuel C; McKenzie AN; Guiguen C; Samson M; Robert-Gangneux F
    mBio; 2013 Sep; 4(5):e00383-13. PubMed ID: 24045639
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leishmanial antigens in liposomes promote protective immunity and provide immunotherapy against visceral leishmaniasis via polarized Th1 response.
    Bhowmick S; Ravindran R; Ali N
    Vaccine; 2007 Aug; 25(35):6544-56. PubMed ID: 17655984
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoprotective responses of T helper type 1 stimulatory protein-S-adenosyl-L-homocysteine hydrolase against experimental visceral leishmaniasis.
    Khare P; Jaiswal AK; Tripathi CD; Sundar S; Dube A
    Clin Exp Immunol; 2016 Aug; 185(2):165-79. PubMed ID: 26898994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor necrosis factor alpha neutralization has no direct effect on parasite burden, but causes impaired IFN-γ production by spleen cells from human visceral leishmaniasis patients.
    Singh N; Kumar R; Engwerda C; Sacks D; Nylen S; Sundar S
    Cytokine; 2016 Sep; 85():184-90. PubMed ID: 27372917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 37.